InsidersTradesSigma
Koninklijke Philips N.V.: insider trades · Netherlands · AFM
AFM:koninklijke-philips-nvNL·AFMMcap 20.8Bn€Healthcare & Pharma
Discover the full directors' dealings record of Koninklijke Philips N.V., a publicly traded company based in Netherlands. Shares trade on NL NL, under the supervision of AFM. Operating in the Healthcare & Pharma sector, Koninklijke Philips N.V. has recorded 95 reports. Market capitalisation: €20.8bn. The latest transaction was reported on 13 May 2026 — Purchase. Among the most active insiders: M.J. van Ginneken. The full history is free.
95
Insider Decl.
0
Thresholds
€2m
69 ops.
Buy Volume
€137,412
9 ops.
Sell Volume
Financial data
Analyst consensus
20 analystsBuy
22.60 €Target 28.00 €35.00 €
Valuation
PER (trailing)21.8x
PER (forward)12.8x
P/Book1.9x
Beta0.92
Balance sheet & cash
Market cap20.79 Bn€
Debt / Equity71%
Profitability & ownership
ROE8.4%
ROA3.5%
% insiders19.0%
% institutions47.5%
Last declaration on 13 May 2026
Declarations95 total
Executives●Purchase10AFM
3,900 shares
New York shares
AFM:193681·
Ideal exit: 7 Feb 2027 (T+270)
Executives●Purchase10AFM
048,061 shares0
Performance award share
AFM:193088·
Ideal exit: 31 Jan 2027 (T+270)
Executives●Purchase10AFM
0117,273 shares0
Performance award share
AFM:193087·
Ideal exit: 31 Jan 2027 (T+270)
Executives●Purchase10AFM
047,433 shares0
Performance award share
AFM:193089·
Ideal exit: 31 Jan 2027 (T+270)
Executives●Mixed12AFM
€1m59,285 shares@ €4.26280.0054% mcap24.6% of flow
Performance award share
AFM:192701·
Executives●Mixed20AFM
€3m150,570 shares@ €4.26270.014% mcap92.2% of flow
Performance award share
AFM:192695·
Executives●Purchase10AFM
0131,846 shares0
Performance award share
AFM:188395·
Ideal exit: 16 Nov 2026 (T+270)
Executives●Purchase10AFM
051,914 shares0
Performance award share
AFM:188402·
Ideal exit: 16 Nov 2026 (T+270)
Executives●Mixed10AFM
€820-4,102 shares@ €0.100.0000% mcap0.0% of flow
Performance award share
AFM:182501·
Executives●Purchase10AFM
0777 shares0
Gewoon aandeel
AFM:176145·
Ideal exit: 10 Mar 2026 (T+270)
Executives●Purchase10AFM
0483 shares0
New York shares
AFM:176023·
Ideal exit: 8 Mar 2026 (T+270)
Executives●Purchase10AFM
0947 shares0
Gewoon aandeel
AFM:176024·
Ideal exit: 8 Mar 2026 (T+270)
Executives●Purchase10AFM
068 shares0
New York shares
AFM:175975·
Ideal exit: 7 Mar 2026 (T+270)
Executives●Purchase10AFM
0141 shares0
New York shares
AFM:175972·
Ideal exit: 7 Mar 2026 (T+270)
Executives●Purchase10AFM
04,839 shares0
Performance award share
AFM:175970·
Ideal exit: 3 Mar 2026 (T+270)
Executives●Purchase10AFM
016,742 shares0
Performance award share
AFM:175969·
Ideal exit: 3 Mar 2026 (T+270)
Executives●Purchase10AFM
06,682 shares0
Performance award share
AFM:175968·
Ideal exit: 3 Mar 2026 (T+270)
Executives●Purchase10AFM
8,176 shares
New York shares
AFM:174593·
Ideal exit: 3 Feb 2026 (T+270)
Executives●Purchase10AFM
050,871 shares0
Performance award share
AFM:174282·
Ideal exit: 31 Jan 2026 (T+270)
Executives●Purchase10AFM
050,871 shares0
Performance award share
AFM:174285·
Ideal exit: 31 Jan 2026 (T+270)
Executives●Purchase10AFM
0120,686 shares0
Performance award share
AFM:174280·
Ideal exit: 31 Jan 2026 (T+270)
Executives●Mixed10AFM
03,181 shares0
Performance award share
AFM:174000·
Executives●Mixed10AFM
03,402 shares0
Performance award share
AFM:174001·
Executives●Sale10AFM
0-58,124 shares0
Performance award share
AFM:170443·
25 of 95 declarations
About Koninklijke Philips N.V.
Koninklijke Philips N.V. is a Dutch company focused on health technology and pharmaceutical products. It is listed on the Amsterdam Stock Exchange.
